Open AccessMitochondrial disorders with significant ophthalmic manifestations
Author(s) -
Mona Al-Enezi,
Hanan Al-Saleh,
Murad Nasser
Publication year - 2008
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.51998
Subject(s) - medicine , mitochondrial disease , mitochondrial myopathy , kearns–sayre syndrome , mitochondrial dna , mitochondrial encephalomyopathy , atrophy , optic neuropathy , myoclonic epilepsy , melas syndrome , lactic acidosis , pathology , chronic progressive external ophthalmoplegia , encephalopathy , optic nerve , ophthalmology , epilepsy , genetics , psychiatry , gene , biology
Mitochondrial diseases are a clinically hetyerogenous group of disorders. They can be caused by mutations of nuclear or mitochondrial DNA (mtDNA). Some affect a single organ, but many involve multiple organ systems and often present with prominent neurologic and myopathic features. The eye is frequently affected, along with muscles and brain, but multisystem disease is common. Ophthalmic manifestations include cataract, retinopathy, optic atrophy, cortical visual loss, ptosis and ophthalmoplegia. Kearns-Sayre Syndrome (KSS), Mitochondrial Encephalopathy, Lactic Acidosis Stroke (MELAS), Myoclonic Epilepsy and Ragged Red Fiber myopathy (MERRF) and Lebers Hereditary Optic Neuropathy (LHON) are well known clinical entities that are secondary to mtDNA abnormalities, which has ophthalmic manifestations. Mitochondrial Dysfunction should be considered in the differential diagnosis of progressive multisystem disorder and specifically if there is associated neuro-ophthalmic manifestations, which may be the presenting symptom of these disorders.